The times from infection with the human immunodeficiency virus (HIV) to the onset ofthe first clinical symptom and the development ofAIDS were studied prospectively in 98 haemophiliacs and 48 blood transfusion recipients infected with the virus. Patients were followed up for a median of 61 months after infection, the dates of infection being either known exactly or estimated from the interval between the last negative and first positive HIV antibody test result. The rate ofprogression to AIDS was significantly higher for the transfusion recipients than for the haemophiliacs. The difference in time to the occurrence of the first clinical symptom was less pronounced between the two groups, though pointing in the same direction.
Introduction
The incubation time from infection with the human immunodeficiency virus (HIV) to the development of AIDS is a factor ofcrucial epidemiological importance. Any prognosis of the course of the epidemic requires knowledge of this value. As with any other infectious disease, however, it is misleading to talk about the incubation time as if it were a constant; instead we should try to describe its distribution-that is, the proportion of infected patients who have developed AIDS as a function of time since infection. Estimates of the distribution of the incubation time of AIDS must rely on studies of patients with known dates of infection. Longitudinal surveys of cohorts of homosexual men,' haemophiliacs,2 and blood transfusion recipients3 are beginning to yield information about the incidence of AIDS up to eight years after infection.
Most published attempts to estimate the distribution of incubation times have been based on data from patients with AIDS in the United States who have contracted HIV from blood transfusions.47 These estimates have been used to make predictions about the future size of the AIDS epidemic.89 There is one serious problem with this approach: the original subjects described by Peterman et al were all patients who already had a diagnosis of AIDS.'0 Nothing is known about the number of people infected by blood transfusions who have not yet developed the disease. As we have only a limited study period, excluding these patients will lead to an underestimate of the average incubation period. Several workers have tried to compensate for this lack of information by assuming some given type of distribution for the incubation time in the entire infected population. They have then fitted this assumed distribution to the observed data to find its probable shape. There is, however, very little firm support for any of these distributions.
In this study we collected data on all Swedish haemophiliacs infected with HIV as well as on all infected recipients of blood from a group of Swedish donors positive for the virus. These 146 patients were closely followed up and the times of appearance of symptoms related to HIV, diagnosis of AIDS, and death recorded. From these complete data it should be possible to obtain a better estimate of the distribution of the incubation time. That every transfusion from an antibody positive donor leads to infection is illustrated by the following. For one donor one of the recipients was found to be antibody negative, whereas several previous and subsequent recipients were antibody positive. Careful review of this patient's medical chart showed that the unit of blood had been ordered from the blood bankand was thus registered as a transfusion-but had never been given to the patient on the ward. We may therefore surmise that 33 of the 169 recipients who had died before the study were also infected and that a further 25 patients were possibly infected. Most of these patients had died within six months after the transfusion. One ofthese 58 patients apparently died of AIDS. A more detailed account of the transfusion recipients will be published elsewhere. ' 
Patients and methods

HAEMOPHILIACS
symptoms but, on the other hand, as more physicians become acquainted with the acute retroviral syndrome the proportion of infections that are detected early ought to increase.
INCUBATION TIME TO AIDS
There was a significant difference (log rank test, p<0-001; Wilcoxon test, p<0001) in the incidence of progression to AIDS between the haemophiliacs and transfusion recipients (fig 2) . Among the haemophiliacs none had developed AIDS three years after seroconversion compared with 1% at four years and 5% at five years. Of the transfusion recipients, 16% had AIDS after three years, 23% after four years, and 29% after five years. Table II summarises some of the studies on incubation times among different groups of patients infected with HIV. Compared with the series of Eyster et aP our haemophiliacs showed a lower incidence of progression to AIDS at four to six years. Our transfusion recipients, however, had a higher incidence of AIDS than reported by Ward et al,'6 though the groups studied were small. Medley et al calculated the distribution ofincubation times among transfusion recipients from a number of known cases of AIDS and estimates of the total number of people infected in this way.5 They predicted only a 20% cumulative incidence after five years, but there was rather large uncertainty in their estimate of the denominator for relative incidence. Though statistical tests failed to show any relation between age at infection and incubation time, it is interesting that the average age in the haemophiliac groups from the treatment centres with lowest incidence was about 30 compared with 35 in the Gothenburg group and 55 in the transfusion recipients. Hence age may possibly play a part in incubation time, which could not be detected in our series because of the small sample size and limited number ofcases (17 cases of AIDS among 148 patients).
More interestingly, of the 10 transfusion recipients who progressed to AIDS during the study, six were infected by the same donor. Blood from this man, however, had been given to 15 of the 48 patients. It is difficult to assess the relevance of this but possibly he carried an especially virulent strain of HIV or had persistently high virus titres.
STATISTICAL ASPECTS Estimation oftime ofinfection
In this series, as in other cohort studies of haemophiliacs and people infected sexually, there was often uncertainty about the time of infection. The usual remedy is to estimate this as the midpoint of the interval between the last negative (or, if this is unknown, a reasonable first possible such date) and the first positive antibody test result. We followed this practice for comparability. This method, however, implicitly presupposes that the risk of infection has been constant during the period including the possible times of infection, in contrast with the commonly held view that the number of infected blood donors-and hence the risk of infection from blood products-has been rising exponentially during the same period. This reasoning was adopted by Taylor et al, who assumed that the risk of infection was increasing linearly on the uncertainty intervals and used this assumption in their estimation of incubation times.'7 The hypothesis of exponential increase leads to the following formula for the estimated time of infection: estimated month of infection=(b-ae-'b-a')/(l-e-Nb-a')-1/p, where b denotes the month of the first positive HIV test result, a the month of the last negative HIV test result, and 1 equals (ln 2)/12=0-058. This choice of 13 corresponds to a doubling time of one year for the risk of infection.
In our data on haemophiliacs we found that the average interval of uncertainty was about three years and that in 39 subjects the first antibody test result was positive. Most of these tests, however, were performed before 1984. It may be noted that the "exponential" estimate is always closer to the right endpoint of the uncertainty interval than is the midpoint.
The effect of the two methods of estimating time of infection on the subsequent analysis ofincubation time before the onset of AIDS was slight owing to the relatively low values achieved by the cumulative incidence in this study, and the highly significant difference between the two groups of patients remained. The effect was seen more easily in the analysis of time to the occurrence of symptoms, where, for example, the 30% quantile in the distribution for haemophiliacs was estimated to be 58 months by the midpoint method and 50 months by the exponential method. Furthermore, the significance of the difference between the subject groups disappeared (log rank test, p-26%; Wilcoxon test, p=8%), though the visual relation between the transfusion recipients and the haemophiliacs remained, the transfusion recipients having symptoms sooner. Thus the difference between the two groups of patients in time to the occurrence of the first clinical symptom was less well established than the difference in time to the onset of AIDS. This seems to be relatively important in the estimation procedure.
Furthermore, when infection transmitted by infusion is compared with other modes of transmission we must remember that in the first case the actual time from infection is measured, whereas in the second the issue is the time from seroconversion, though many authors, ourselves included, often use these words interchangeably. The difference is probably negligible in most instances.
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Bias in resulting estimate ofdistnibution It is perhaps more surprising that any method of estimating the time of infection by a single time point will result in the estimation of a biased distribution of incubation time. The exact resulting perturbation of the distribution is difficult to predict but plainly, for example, the variance will be overestimated, as the times subject to analysis will have 
Abstract
The clinical features of ulcerative colitis and Crohn's disease are similar to those of infections of the bowel, although their cause is uncertain. Many bacteria that cause intestinal diseases adhere to the gut mucosa, and adhesion of pathogenic Escherichia coli is resistant to D-mannose. The adhesive properties of isolates of E coli were assessed by assay of adhesion to buccal epithelial cells with mannose added. The isolates were obtained from patients with inflammatory bowel diseases (50 with a relapse of ulcerative colitis, nine with ulcerative colitis in remission, 13 with Crohn's disease, and 11 with infectious diarrhoea not due to E coli) and 22 controls.
The median index of adhesion to buccal epithelial cells (the proportion of cells with more than 50 adherent bacteria) for E coli from patients with ulcerative colitis in relapse was significantly higher (43%) than that for controls (5%) and patients with infectious diarrhoea (14%). The index was not significantly different among isolates from patients with ulcerative colitis in relapse, Crohn's disease (53%), and ulcerative colitis in remission (30%). If an index of adhesion of >25% is taken as indicating an adhesive strain 86% of isolates of E coli from patients with inflammatory bowel disease were adhesive compared with 27% from patients with infective diarrhoea and none from controls.
The adhesive properties of the isolates from patients with inflammatory bowel disease were similar to those of pathogenic intestinal E coli, raising the possibility that they may have a role in the pathogenesis of the condition; the smaller proportion of adhesive isolates in patients with infective diarrhoea due to other bacteria suggests that the organism may be of primary importance rather than arising secondarily.
Introduction
Mucosal adhesion is a virulence factor that is expressed by pathogenic Escherichia coli in the intestine. Enterotoxigenic strains of E coli are recognised
